TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rates of change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cough score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BIS levels from EEG monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ANI scores from analgesia-nociception monitor (0-100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Location of key anatomical locations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Efficacy for Hearing Loss Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Efficacy for Chronic Health Condition Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average concentration at steady state (Css-avg) in breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the concentration-time curve over the dosing interval (AUCtau) in breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drug daily infant dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drug relative infant dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to tDCS
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse Events reported
Endpoint domain: Adverse events/effects
Primary endpoint: Safety measures of clozapine treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Psychomotor Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preliminary breath test for ethanol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidentiary breath test for ethanol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard Field Sobriety Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal clinical laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower limb alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee prosthesis position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Foot Ulcer Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunnybrook facial grading scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Clinimetric Evaluation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Meyer (FM) motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Patient satisfaction with outpatient care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Local Control
Endpoint domain: Mortality/survival
Primary endpoint: Progression incidence of esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients starting adjuvant chemotherapy within 2 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline in respiratory visual analogue scale symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of treatment non response
Endpoint domain: Adverse events/effects
Primary endpoint: Food Literacy Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mindful Eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diet quality using the Diet Quality Index Score (DQIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in chronic pain acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in symptoms of depression and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance of the preoperative palliative counseling offer
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Sexual Life Quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in satisfaction with sexual life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in satisfaction with marital relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Excess oxygen consumption after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static balance assessment-Postural Stability Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static balance assessment-Stability Limit Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static balance assessment-Modified Sensori Organization Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Scores on the Cox Menstrual Symptom Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reasons for not scheduling or attending appointments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Cheeks Fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of missing teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Function measured with Disability of the Arm, Shoulder and Hand (DASH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in Function measured with Constant-Murley Score (CMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in Function measured with Upper Limb Functional Index (ULFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Accuracy of elastography in assessing lymph nodes response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of PD-1 and PD-L1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients developing severe COVID-19 infection
Endpoint domain: Mortality/survival
Primary endpoint: Pain reduction of at least 1 point on the VAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to successful weaning from respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Burn Specific Health Scale measurements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intraoperative pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at 1 hour after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at 6 hours after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at 12 hours after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity at 24 hours after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cathelicidin LL-37 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive Bacterial Culture Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: RSV A serum neutralizing antibody (Nab) titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RSV B serum Nab titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of ARD associated with any RT PCR confirmed RSV strain during the study
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of LRTD associated with any RT PCR confirmed RSV strain during the study
Endpoint domain: Adverse events/effects
Primary endpoint: relative/LAR perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tissue distribution of 68Ga-Anti-PSMA mAbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myoblast differentiation capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia Severity Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bolus Residual Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Sleep Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Pressure Algometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum anti-Müllerian hormone (AMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change on gait function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline in Disease Activity Score (DAS28/ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in scores on the self-reported sleep quality measure using the Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in scores on the Insomnia Severity Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in objective sleep quality as measured by the sleep efficiency index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell killing rate of anti-CD19 CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent change in low-density lipoprotein cholesterol (LDL-C) from baseline to Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Major Clinical and Angiographic Complications (MCAC)
Endpoint domain: Adverse events/effects
Primary endpoint: Participant recruitment rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of assigned study procedures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical improvement in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: dyspnea clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Evolution of neurological evaluation clinical scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional clinical scales
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Monthly facility percent of inappropriate medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Frailty Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with improvement of fat fraction by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Attention Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of Shame Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Distress Disclosure Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Salivary Alpha-Amylase change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Mood State Questionnaire (MDMQ) Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale (VAS) for Anxiety Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale (VAS) for Pain Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with PADIS guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of nonserious treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: marginal recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Difference in lidocaine concentrations in tumor tissue vs blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Whole body lean soft tissue mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Whole body fat mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in regional (specifically the lower extremity) lean soft tissue mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in regional (specifically the lower extremity) fat mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who completed course of NT-I7
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Detection of recurrent BCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Genetic Testing Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence Rate of Positive Genetic Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of chest tube drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMD17 reduction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypotension event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vasopressor (total amount)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of subjects with SALT score <= 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients exposed to each type of regimen by line of therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients with objective response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oncologic strains in HPV DNA salivary samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SHUTi Engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hopkins Symptom Checklist-25 (HSCL-25)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Beck Scale for Suicidal Ideation (BSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of boluses of vasopressor during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-reported smoking cessation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NRS (Numeric Rating Scale) at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rates of the neutralizing antibody at 4 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of the neutralizing antibody at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Complete or Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who are Alive and in Remission
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity of ImmunoPET to identify adenocarcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Condom Use from Baseline to Month 1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Condom Use from Baseline to Month 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Pre-exposure Prophylaxis [PrEP] Awareness from Baseline to Month 1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Pre-exposure Prophylaxis [PrEP] Awareness from Baseline to Month 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Pre-exposure Prophylaxis [PrEP] Access from Baseline to Month 1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Metronidazole penetrance through the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of women who complete cervical cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women who test HPV-positive and access treatment within 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge level of cervical cancer
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: End tidal sevoflurane concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and feasibility
Endpoint domain: Adverse events/effects
Primary endpoint: antitumor effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of liver recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in purine after rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in histidine after rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in galactose after rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: H-Reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EMG detection of spontaneous electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Numeric Pain Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Self-Efficacy for Diabetes Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of reversible causes in OHCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Inter-muscular adipose tissue (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of GST-HG171
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diaphragm movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lung field area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lung field area change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Validity of the POP scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change individual quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change physical activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Variation of serum level of vitamin B12 (pmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hamilton Anxiety Rating Scale (HAM-A) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hamilton Depression Rating Scale (HAM-D) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Periapical Index (PAI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects reclassified from pathological to normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life concerns (ESAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life concerns (MYCAW)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life concerns (EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: State/Trait Anxiety Inventory (SAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental Fever Management Scale-Turkish Version (PFMS-TR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Active joint position sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flexion-extension strengths of the wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Grip and pinch strengths
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes